Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

<p xmlns="https://www.w3.org/1999/xhtml">SUZHOU, <span class="xn-location">China, <span class="xn-chron">Jan. 10, 2021 /PRNewswire/ — Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted…

This post was originally published on this site